DELEGATE REGISTRATION · LONDON · JUNE 2027
Two days of expert insight, investor roundtables, educational briefings, structured networking and deal-enabling dialogue — for the investors, family offices, private wealth owners, clinicians, policymakers and industry leaders shaping the future of UK medical cannabis.
THE SUMMIT EXPERIENCE
The UK Medical Cannabis Investment Summit 2027 is not a trade show or a general networking event. It is a senior closed forum — deliberately small, deliberately selective — where verified investors, family offices, private wealth owners, clinicians, policymakers and industry leaders gather for two days of substantive insight, private dialogue and purposeful connection.
Whether you are an active investor in the UK medical cannabis sector, a family office principal or private wealth owner evaluating your first allocation, a clinician seeking to understand the investment landscape, or a policymaker or adviser embedded in the sector — the Summit is designed for you.
Two full days of expert-led sessions, closed investor roundtables, educational briefings, structured one-to-one meetings and private networking — covering the investment landscape, regulatory environment, clinical evidence, market intelligence and the global context shaping UK medical cannabis in 2027 and beyond.
Day One Morning
Expert-led plenary sessions covering the current state of the UK medical cannabis market, capital flows, regulatory developments, clinical evidence and the international investment landscape. Designed to bring every attendee — from the newly curious family office to the experienced operator — to the same informed level before the day's dialogue begins.
Day One Mid-Morning
Small closed-group roundtable discussions on focused investment themes — family office allocation strategies, venture capital in medical cannabis, private equity deal structuring, clinical network investment and cross-border capital flows. Chatham House Rule applies throughout.
Day One Afternoon
Direct dialogue between investors and the UK's most promising medical cannabis founders, operators and innovators. The Dealflow Session gives investors front-row access to the businesses and people driving the sector's commercial development.
Day One Evening
A closed invitation-only drinks reception for all Summit delegates. The informal continuation of the day's conversations — in a relaxed, premium setting with every verified investor, family office and industry leader in the room.
Day Two
Senior policy and regulatory sessions examining MHRA developments, NHS commissioning strategy, the conditions for market expansion and the legislative landscape shaping investment returns in 2027 and beyond. Followed by structured one-to-one meetings and a closing plenary.
WHO SHOULD ATTEND
Attendance is open to verified senior professionals with a direct investment, clinical, policy or operational role in the UK medical cannabis sector. All registrations are subject to verification and approval.
Single family office principals, CIOs and investment committees with direct mandates — whether currently invested in medical cannabis or evaluating the opportunity for the first time.
High and ultra-high net worth individuals and family wealth owners considering direct investment or co-investment allocations into the UK medical cannabis sector.
Healthcare-focused fund managers, asset managers and institutional allocators with existing or prospective positions in medical cannabis, life sciences and healthcare investment.
PE and VC professionals actively deploying or evaluating capital across UK medical cannabis operators, clinic networks, technology platforms and supply chain businesses.
Chief executives, founders and senior operators of licensed medical cannabis clinics, cultivation businesses, pharmacy networks and technology companies.
Senior clinicians, prescribers and researchers providing evidence-based insight into patient outcomes, clinical development and the evolving evidence base for medical cannabis.
Government officials, MHRA representatives and policy advisers shaping the regulatory and legislative environment for medical cannabis in the United Kingdom.
Specialist solicitors, accountants, tax advisers and consultants active in medical cannabis transactions, licensing, compliance and investment structuring.
DELEGATE PASS OPTIONS
Places are strictly limited. All registrations are subject to verification and approval. Early bird rate available until 10 January 2027.
£595 + VAT
Early Bird — Book Before 10 January 2027
£995 + VAT from 11 January 2027
Early bird £595 + VAT until 10 January 2027. Full rate £995 + VAT from 11 January 2027.
Register InterestThis pass is not for sale.
Complimentary attendance is strictly limited to verified single family office principals and CIOs principally managing the private wealth of one family — with assets under management of £200 million or above.
Not institutional allocators. Not multi-family offices. Not advisers. Not funds. Not service providers.
Eligibility is verified by the UKMC Group Ltd events team prior to confirmation. A limited number of Complimentary Single Family Office Principal Passes are available at the UK Medical Cannabis Investment Summit 2027.
If you are a single family office principal or CIO managing £200 million or above — apply now. Places are allocated on a first-verified basis and go quickly.
Not everyone who calls themselves a family office principal is one. Our verification process exists to make sure every person in the room is exactly who they say they are.
The Complimentary Single Family Office Principal Pass is strictly limited to verified single family office principals and CIOs managing the private wealth of one family with assets under management of £200 million or above. Institutional allocators, multi-family offices, advisers, funds and service providers are not eligible. Subject to verification and approval by the UKMC Group Ltd events team. UKMC Group Ltd reserves the right to decline any application without providing a reason.
Complimentary Single Family Office Principal Pass · £200M+ AUM Only
The Complimentary Single Family Office Principal Pass is available exclusively to single family office principals and CIOs managing the private wealth of one family with assets under management of £200 million or above. Institutional allocators, multi-family offices, advisers, funds and service providers are not eligible. All applications are reviewed and verified by the UKMC Group Ltd events team before a place is confirmed. Submitting this form does not guarantee a pass. You will receive a response within five working days.
The Complimentary Single Family Office Principal Pass is strictly for single family office principals and CIOs managing the private wealth of one family with assets under management of £200 million or above. Institutional allocators, multi-family offices, advisers, funds and service providers are not eligible. All applications are subject to verification and approval by the UKMC Group Ltd events team. A limited number of passes are available. Submission does not guarantee attendance. UKMC Group Ltd reserves the right to decline any application without providing a reason. Your data is held securely and used solely for the purposes of verifying your application and communicating with you about the Summit. Contact: info@ukmcgroup.co.uk
REGISTER YOUR INTEREST
Complete the form to register your interest. The UKMC Group Ltd events team will be in touch within five working days to confirm your registration and provide payment details. Early bird rate of £595 + VAT applies to all registrations confirmed before 10 January 2027.
Summit Delegate Pass: Early Bird £595 + VAT per person (book by 10 January 2027). Full rate £995 + VAT per person from 11 January 2027. Full two-day access. Complimentary passes are subject to verification and approval. All registrations subject to review by the UKMC Group Ltd events team. The UK Medical Cannabis Investment Summit 2027 is a two-day event organised by UKMC Group Ltd. Nothing communicated at or in connection with the Summit constitutes financial, investment or legal advice. Contact: info@ukmcgroup.co.uk
FREQUENTLY ASKED QUESTIONS
The Summit is open to investors and fund managers, single family office principals and CIOs, private wealth owners, institutional allocators, private equity and venture capital professionals, medical cannabis operators and executives, clinicians and researchers, policymakers and regulators, and legal and financial advisers active in the UK medical cannabis sector. Attendance is by application and verification only. All registrations are reviewed by the UKMC Group Ltd events team.
The Summit Delegate Pass is £595 + VAT per person for registrations confirmed before 10 January 2027 (early bird rate). The full rate of £995 + VAT applies from 11 January 2027. Both rates provide full two-day access to all sessions, roundtables, networking breaks, lunches and the Day One evening drinks reception. A complimentary pass is available to qualifying family office principals, institutional LPs and private wealth owners — subject to verification and approval.
The early bird rate of £595 + VAT is available for all registrations confirmed before 10 January 2027. The full rate of £995 + VAT applies from 11 January 2027. We recommend registering early to secure your place at the lower rate.
Yes. The Summit is specifically designed to be educational as well as deal-enabling. Day One opens with market intelligence and investment briefings that bring every attendee — from the newly curious family office to the experienced operator — to the same informed level. The programme covers the investment landscape, clinical evidence, regulatory environment and market intelligence in a structured and accessible format.
The Complimentary Investor Pass provides full two-day access — identical to the Summit Delegate Pass — at no cost to qualifying family office principals managing £100 million or above, institutional LPs and qualifying private wealth owners. Applications are subject to verification and approval by the UKMC Group Ltd events team. Places are strictly limited.
The UK Medical Cannabis Investment Summit 2027 takes place in London in June 2027. The exact venue will be confirmed to registered delegates. The venue is selected to reflect the senior and institutional nature of the forum.
After submitting your registration, the UKMC Group Ltd events team will be in touch within five working days to confirm your place and provide payment details. Payment is required to confirm your registration.
Yes. Every sponsorship package includes at least one full two-day delegate pass. If you are interested in sponsoring as well as attending, visit our Sponsors page or contact info@ukmcgroup.co.uk.
Cancellation and refund terms will be confirmed at the point of registration. For any queries contact info@ukmcgroup.co.uk.